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Study Objective: Enhanced Recovery After Surgery (ERAS) pathways
are evidence-based practices aimed at minimizing perioperative physiologic stress responses. This reduces recovery time, hospital-stay length,
postoperative complications, and hospital cost per patient. The objective
of this study was to assess the Canadian application of and adherence to
ERAS protocols during minimally invasive gynecologic surgery. We also
aimed to identify facilitators and barriers to ERAS uptake in our
population.
Design: A self-administered cross-sectional survey was distributed via
three listservs (Canadian Ob/Gyn residency programs, CanSAGE, and the
Society of Obstetricians and Gynecologists of Canada [SOGC]) between
February 2021 to January 2022. The survey assessed 14 perioperative components as per the American Association of Gynecologic Laparoscopists
(AAGL) ERAS consensus guidelines.
Setting: N/A.
Patients or Participants: Canadian Ob/Gyn residents, fellows, and
attendings.
Interventions: N/A.
Measurements and Main Results: 157 responses were analyzed. Majority of respondents (77%) are attendings and work in academic hospitals
(48%). Only 41% of respondents work within an established ERAS program. Majority of respondents engage in preoperative anemia optimization, although targets varied with 43% targeting Hemoglobin>120g/L.
The proportion of respondents that engaged in other preoperative interventions (e.g., lifestyle modification) varied. While most counselled on hyperglycemia and obstructive sleep apnea, a smaller proportion (16-39%)
addressed obesity, smoking cessation, and alcohol intake; notably, this
was consistent across sites with and without established ERAS programs.
Respondents had a high adherence to intraoperative practices including
VTE prophylaxis (83%), early feeding (98%), and early ambulation
(89%). There was poor adherence to perioperative fasting times, preoperative carbohydrate loading, and intraoperative IV fluids. Most respondents
felt ERAS pathways were safe (98%) and improved patient outcomes
(82%).
Conclusion: While the implementation of formal ERAS pathways differs between provinces and hospitals, practitioners engage in various
ERAS components as per consensus guidelines. Future and targeted
research around ERAS components with lower adherence would be
beneficial in identifying and addressing barriers to optimize surgical
care.
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Study Objective: To evaluate if cefazolin plus metronidazole before a
hysterectomy will be more effective in prevention of surgical site infection
(SSI) and sepsis compared to the existing recommendation of preoperative
cefazolin alone.
Design: Retrospective chart review.
Setting: Henry Ford Health System (HFHS).
Patients or Participants: Data was collected for 1485 adult patients who
received hysterectomies within HFHS for benign and malignant conditions. The control group (group 1) was obtained via retrospective chart
review to include patients who had a hysterectomy between January 2019
and June 2020 and received cefazolin alone as antibiotic prophylaxis. The
treatment group (group 2) included patients who had a hysterectomy
between July 2020 and January 2022 and received preoperative cefazolin
plus metronidazole.
Interventions: Addition of metronidazole to cefazolin as antibiotic prophylaxis prior to hysterectomy.
Measurements and Main Results: Of the 1485 patients, 789 (53.1%)
were given cefazolin alone and 696 (46.9% were given cefazolin plus metronidazole. There was a total of six (0.4%) patients who experienced sepsis
and 37 (2.5%) who had a site infection across both groups. There was a
decrease in both sepsis and SSI in group 2, however it did not reach statistical significance. The model for the risk of sepsis is adjusted for obesity
(BMI ≥30), procedure length >2 hours, and gynecologic cancer. We found
that there were no significant differences in the risk of sepsis between the
two treatment groups after adjusting for these risk factors (p=0.736). The
model for the risk of site infection is adjusted for diabetes, obesity, smoking status, procedure length, and gynecologic cancer. We found that there
were no significant differences in the risk of site of infection between the
two treatment groups (p=0.451).
Conclusion: The addition of metronidazole to the standard antibiotic prophylaxis regimen for hysterectomy did not significantly reduce the rate of
surgical site infections or sepsis within our health system.
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Study Objective: To synthesize the literature in which ultrasound elastography (UE) has been used in benign gynecology and identify avenues for
future research and clinical implementation.
Design: A structured search of EMBASE and Medline databases, last conducted on April 15th, 2022.
Setting: N/A.
Patients or Participants: Eligible studies included adult participants with
female pelvises.
Interventions: English language papers focusing on the utility of ultrasound elastography applied to benign gynecology were included. Narrative
reviews, conference abstracts, and letters to the editor were excluded. Two
independent reviewers screened titles and abstracts for inclusion, a third
reviewer was consulted in the case of disagreement. Study quality was
assessed by a customized checklist for study implementation and elastography technique. Extracted data points included type of elastography,
gynecologic application, opportunities for clinical implementation, and
technology strengths and limitations.
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